{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:44:04Z","timestamp":1790707444167,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Model animals are valuable resources for dissecting basic aspects of the regulation of obesity and metabolism. The translatability of results relies on understanding comparative aspects of molecular pathophysiology. Several studies have shown that despite the presence of overt obesity and dyslipidemia in the pig key human pathological hepatic findings such as hepatocellular ballooning and abundant steatosis are lacking in the model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>The aim of this study was to elucidate why these histopathological characteristics did not occur in a high fat, fructose and cholesterol (FFC) diet-induced obese G\u00f6ttingen Minipig model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>High-throughput expression profiling of more than 90 metabolically relevant genes was performed in liver, subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) of male minipigs diet fed: standard chow (SD, <jats:italic>n<\/jats:italic>\u2009=\u20097); FFC diet (<jats:italic>n<\/jats:italic>\u2009=\u200914); FFC diet in streptozotocin-induced diabetic pigs (FFC<jats:sub>DIA<\/jats:sub>, <jats:italic>n<\/jats:italic>\u2009=\u20098). Moreover, histopathological assessment of SAT and VAT was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>12, 4 and 1 genes were highly significantly differentially expressed in liver, SAT and VAT when comparing the FFC and SD groups whereas the corresponding numbers were 15, 2, and 1 when comparing the FFC<jats:sub>DIA<\/jats:sub> and SD groups. Although the minipigs in both FFC groups developed sever obesity and dyslipidemia, the insulin-signaling pathways were not affected. Notably, four genes involved in lipid acquisition and removal, were highly deregulated in the liver: <jats:italic>PPARG, LPL, CD36 and FABP4<\/jats:italic>. These genes have been reported to play a major role in promoting hepatic steatosis in rodents and humans. Since very little macrophage-associated pro-inflammatory response was detected in the adipose tissues the expansion appears to have no adverse impact on adipose tissue metabolism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study shows that morbidly obese G\u00f6ttingen Minipigs are protected against many of the metabolic and hepatic abnormalities associated with obesity due to a remarkable ability to expand the adipose compartments to accommodate excess calories.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41387-020-0112-y","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T18:03:24Z","timestamp":1584986604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The expression signatures in liver and adipose tissue from obese G\u00f6ttingen Minipigs reveal a predisposition for healthy fat accumulation"],"prefix":"10.1038","volume":"10","author":[{"given":"Susanna","family":"Cirera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emirhan","family":"Ta\u015f\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Juul Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Schumacher-Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"\u00d8stergaard Christoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Kaae Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Pagh Ludvigsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Hvid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Duelund Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"H\u00f8ier Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-7648","authenticated-orcid":false,"given":"Merete","family":"Fredholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"112_CR1","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","volume":"65","author":"JM Hazlehurst","year":"2016","unstructured":"Hazlehurst, J. M., Woods, C., Marjot, T., Cobbold, J. F. & Tomlinson, J. W. Non-alcoholic fatty liver disease and diabetes. Metabolism 65, 1096\u20131108 (2016).","journal-title":"Metabolism"},{"key":"112_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3803\/EnM.2015.30.4.522","volume":"30","author":"M-K Lee","year":"2015","unstructured":"Lee, M.-K. et al. Metabolic health is more important than obesity in the development of nonalcoholic fatty liver disease: a 4-year retrospective study. Endocrinol. Metab. 30, 522\u2013530 (2015).","journal-title":"Endocrinol. Metab."},{"key":"112_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.tem.2015.01.006","volume":"26","author":"B Gustafson","year":"2015","unstructured":"Gustafson, B., Hedjazifar, S., Gogg, S., Hammarstedt, A. & Smith, U. Insulin resistance and impaired adipogenesis. Trends Endocrinol. Metab. 26, 193\u2013200 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"112_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.soard.2010.05.013","volume":"7","author":"OT Hardy","year":"2011","unstructured":"Hardy, O. T. et al. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity. Surg. Obes. Relat. Dis. 7, 60\u201367 (2011).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"112_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060237","volume":"6","author":"S Virtue","year":"2008","unstructured":"Virtue, S. & Vidal-Puig, A. It\u2019s not how fat you are, it\u2019s what you do with it that counts. PLoS Biol. 6, e237 (2008).","journal-title":"PLoS Biol."},{"key":"112_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/joim.12827","volume":"284","author":"RJF Loos","year":"2018","unstructured":"Loos, R. J. F. & Kilpel\u00e4inen, T. O. Genes that make you fat, but keep you healthy. J. Intern Med. 284, 450\u2013463 (2018).","journal-title":"J. Intern Med."},{"key":"112_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jnutbio.2015.09.029","volume":"28","author":"SJ Li","year":"2016","unstructured":"Li, S. J. et al. A nutritional nonalcoholic steatohepatitis minipig model. J. Nutr. Biochem. 28, 51\u201360 (2016).","journal-title":"J. Nutr. Biochem."},{"key":"112_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113724","volume":"9","author":"J Xia","year":"2014","unstructured":"Xia, J. et al. Transcriptome analysis on the inflammatory cell infiltration of nonalcoholic Steatohepatitis in Bama Minipigs induced by a long-term high-fat, high-sucrose diet. PLoS ONE 9, e113724 (2014).","journal-title":"PLoS ONE"},{"key":"112_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/hep.22904","volume":"50","author":"L Lee","year":"2009","unstructured":"Lee, L. et al. Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Hepatology 50, 56\u201367 (2009).","journal-title":"Hepatology"},{"key":"112_CR10","doi-asserted-by":"publisher","unstructured":"Bell, L. N. et al. Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Am. J. Physiol. Gastrointest. Liver Physiol. https:\/\/doi.org\/10.1152\/ajpgi.00485.2009 (2010).","DOI":"10.1152\/ajpgi.00485.2009"},{"key":"112_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124173","volume":"10","author":"T Liang","year":"2015","unstructured":"Liang, T. et al. Liver injury and fibrosis induced by dietary challenge in the Ossabaw miniature Swine. PLoS ONE 10, e0124173 (2015).","journal-title":"PLoS ONE"},{"key":"112_CR12","doi-asserted-by":"publisher","unstructured":"Schumacher-Petersen, C. et al. Experimental non-alcoholic Steatohepatitis in G\u00f6ttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes. J. Transl. Med. https:\/\/doi.org\/10.1186\/s12967-019-1854-y (2019).","DOI":"10.1186\/s12967-019-1854-y"},{"key":"112_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep13980","volume":"5","author":"SL Yang","year":"2015","unstructured":"Yang, S. L. et al. Hyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigs. Sci. Rep. 5, 13980 (2015).","journal-title":"Sci. Rep."},{"key":"112_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178828","volume":"12","author":"SD Frederiksen","year":"2017","unstructured":"Frederiksen, S. D. et al. Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals. Plos ONE 12, e0178828 (2017).","journal-title":"Plos ONE"},{"key":"112_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12986-018-0303-x","volume":"15","author":"LJ Andreasen","year":"2018","unstructured":"Andreasen, L. J. et al. Dietary normalization from a fat, fructose and cholesterol-rich diet to chow limits the amount of myocardial collagen in a G\u00f6ttingen Minipig model of obesity. Nutr. Metab. 15, 64 (2018).","journal-title":"Nutr. Metab."},{"key":"112_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-472","volume":"6","author":"S Cirera","year":"2013","unstructured":"Cirera, S. Highly efficient method for isolation of total RNA from adipose tissue. BMC Res. Notes 6, 472 (2013).","journal-title":"BMC Res. Notes"},{"key":"112_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00438-017-1369-2","volume":"293","author":"CMJ Mentzel","year":"2018","unstructured":"Mentzel, C. M. J. et al. Deregulation of obesity-relevant genes as a result of progression in BMI and amount of adipose tissue in pigs. Mol. Genet. Genomics. 293, 129\u2013136 (2018).","journal-title":"Mol. Genet. Genomics."},{"key":"112_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-8-67","volume":"8","author":"AB Nygard","year":"2007","unstructured":"Nygard, A. B., J\u00f8rgensen, C. B., Cirera, S. & Fredholm, M. Selection of reference genes for gene expression studies in pig tissues using SYBR green qPCR. BMC Mol. Biol. 8, 67 (2007).","journal-title":"BMC Mol. Biol."},{"key":"112_CR19","unstructured":"RStudio Team. RStudio: Integrated Development for R. RStudio, Inc. Boston http:\/\/www.rstudio.com\/ (2015)."},{"key":"112_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167285","volume":"11","author":"CM Mentzel","year":"2016","unstructured":"Mentzel, C. M. et al. Joint profiling of miRNAs and mRNAs reveals miRNA mediated gene regulation in the G\u00f6ttingen Minipig obesity model. PLoS ONE 11, e0167285 (2016).","journal-title":"PLoS ONE"},{"key":"112_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","volume":"123","author":"M Lehrke","year":"2005","unstructured":"Lehrke, M. & Lazar, M. A. The many faces of PPARG. Cell 123, 993\u2013999 (2005).","journal-title":"Cell"},{"key":"112_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tips.2004.03.012","volume":"25","author":"SM Rangwala","year":"2004","unstructured":"Rangwala, S. M. & Lazar, M. A. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol. Sci. 25, 331\u2013336 (2004).","journal-title":"Trends Pharmacol. Sci."},{"key":"112_CR23","doi-asserted-by":"publisher","first-page":"15712","DOI":"10.1073\/pnas.2536828100","volume":"100","author":"W He","year":"2003","unstructured":"He, W. et al. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl Acad. Sci. USA 100, 15712\u201315717 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"112_CR24","doi-asserted-by":"publisher","first-page":"E1195","DOI":"10.1152\/ajpendo.00513.2004","volume":"288","author":"SE Schadinger","year":"2005","unstructured":"Schadinger, S. E., Bucher, N. L., Schreiber, B. M. & Farmer, S. R. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288, E1195\u2013E1205 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"112_CR25","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1096\/fj.10-173716","volume":"25","author":"E Mor\u00e1n-Salvador","year":"2011","unstructured":"Mor\u00e1n-Salvador, E. et al. Role for PPAR\u03b3 in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. FASEB J. 25, 2538\u20132550 (2011).","journal-title":"FASEB J."},{"key":"112_CR26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1210\/jc.2010-2129","volume":"96","author":"P Pettinelli","year":"2011","unstructured":"Pettinelli, P. & Videla, L. A. Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. J. Clin. Endocrinol. Metab. 96, 1424\u20131430 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"112_CR27","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/liv.13639","volume":"38","author":"KJ Thompson","year":"2018","unstructured":"Thompson, K. J. et al. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma. Liver Int. 38, 1074\u20131083 (2018).","journal-title":"Liver Int."},{"key":"112_CR28","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.2337\/db07-0907","volume":"56","author":"DP Koonen","year":"2007","unstructured":"Koonen, D. P. et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 56, 2863\u20132871 (2007).","journal-title":"Diabetes"},{"key":"112_CR29","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1073\/pnas.121164498","volume":"98","author":"JK Kim","year":"2001","unstructured":"Kim, J. K. et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. PNAS 98, 7522\u20137527 (2001).","journal-title":"PNAS"},{"key":"112_CR30","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1194\/jlr.M065011","volume":"57","author":"G Liu","year":"2016","unstructured":"Liu, G. et al. Regulation of plasma lipid homeostasis by hepatic lipoprotein lipase in adult mice. J. Lipid Res. 57, 1155\u20131161 (2016).","journal-title":"J. Lipid Res."},{"key":"112_CR31","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/jn\/135.11.2499","volume":"135","author":"WG Berger","year":"2005","unstructured":"Berger, W. G. & Mersmann, H. J. Comparative aspects of lipid metabolism: Impact on contemporary research and use of animal models. J. Nutr. 135, 2499\u20132502 (2005).","journal-title":"J. Nutr."},{"key":"112_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/hep.23721","volume":"52","author":"T Li","year":"2010","unstructured":"Li, T. et al. Transgenic expression of cholesterol 7 alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance. Hepatology 52, 678\u2013690 (2010).","journal-title":"Hepatology"},{"key":"112_CR33","doi-asserted-by":"publisher","first-page":"E439","DOI":"10.1002\/oby.20135","volume":"21","author":"IJ Neeland","year":"2013","unstructured":"Neeland, I. J. et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity 21, E439\u2013E447 (2013).","journal-title":"Obesity"},{"key":"112_CR34","doi-asserted-by":"publisher","unstructured":"Clemente-Postigo, M. et al. Metabolic endotoxemia promotes adipocyte dysfunction and inflammation in human obesity. Am. J. Physiol. Endocrinol. Metab. https:\/\/doi.org\/10.1152\/ajpendo.00277 (2018).","DOI":"10.1152\/ajpendo.00277"},{"key":"112_CR35","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/oby.20809","volume":"22","author":"T Auguet","year":"2014","unstructured":"Auguet, T. et al. Downregulation of lipogenesis and fatty acid oxidation in the subcutaneous adipose tissue of morbidly obese women. Obesity 22, 2032\u20132038 (2014).","journal-title":"Obesity"},{"key":"112_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ijo.2010.216","volume":"35","author":"V Primeau","year":"2011","unstructured":"Primeau, V. et al. Characterizing the profile of obese patients who are metabolically healthy. Int. J. Obes. 35, 971\u2013981 (2011).","journal-title":"Int. J. Obes."},{"key":"112_CR37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2007.04.013","volume":"47","author":"B Balas","year":"2007","unstructured":"Balas, B. et al. Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. J. Hepatol. 47, 565\u2013570 (2007).","journal-title":"J. Hepatol."},{"key":"112_CR38","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa060326","volume":"355","author":"R Belfort","year":"2006","unstructured":"Belfort, R. et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355, 2297\u20132307 (2006).","journal-title":"N. Engl. J. Med."},{"key":"112_CR39","doi-asserted-by":"publisher","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","volume":"270","author":"JM Lehmann","year":"1995","unstructured":"Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270, 12953\u201312956 (1995).","journal-title":"J. Biol. Chem."}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-020-0112-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-020-0112-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-020-0112-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:25:24Z","timestamp":1670246724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-020-0112-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1038\/s41387-020-0112-y","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.\u00d8.C., R.K.K., T.L.P., and H.H. are full time employed at Novo Nordisk A\/S. H.D.P. is full time employed at Ellegaard G\u00f6ttingen Minipigs A\/S. The remaining authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"9"}}